Structural

Can We Do Better? Next Generation LAAO Devices

12 min.

AF Patients at Highest Bleeding Risks: How Should We Individualize Postimplant Medical Therapy?

7 min.

Ultimate Stroke Prevention: LAAO in Association With Medical Therapy/Other Procedures

6 min.

LAAO as First Line Stroke Prevention Therapy: Are CHAMPION-AF and CATALYST Trials Likely to Succeed?

6 min.

No: The Transcatheter Devices Have Much Better Results

9 min.

Yes: Based on LAAOS III, All LAA Should Be Ligated at the Time of Concurrent Heart Surgery

4 min.

LAAO: Follow-up Postprocedural Imaging: CT Should Be the New Gold Standard

10 min.

Histomorphometric and Histopathologic Findings in Patients Undergoing Left Atrial Appendage Closure With Use of a Double-Filter Embolic Protection Device

11 min.

First-in-Human Experience with the Novel Watchman FLX Pro Device: Results of the Watchman FLX Pro CT study

11 min.

US Early Feasibility Study Evaluating the Safety and Efficacy of Rotational Closure of the Left Atrial Appendage Using the Laminar Device in Patients with Non-Valvular Atrial Fibrillation

14 min.

Percutaneous Left Atrial Appendage Closure Versus Chronic Oral Anticoagulation for Non-Valvular Atrial Fibrillation: An Individual Patient Data Level Meta-Analysis of Randomized Controlled Trials

8 min.

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

12 min.

This Is the Way I Do Watchman FLX: Please Disagree With Every Single Step!

42 min.

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

19 min.

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results

20 min.

LAAC Device Surveillance: Significance of Peri-Device Leaks and Device-Related Thrombus

8 min.

Amulet

5 min.

Watchman Flex

3 min.

LAAO vs DOACs: Ongoing Trials and My Prediction

8 min.

Current FDA-Approved Devices: How to Select; Lesion-Specific Differences

6 min.

LAA Closure Clinical Trial & Registry Update 2022

4 min.

Ongoing Clinical Trials and the Future of LAAC

5 min.